Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Awano

Showing results (81-90 of 152) with videos related to

Pageof 16
Sort By:
Gene|November 6, 2012
A Japanese child with geleophysic dysplasia caused by a novel mutation of FBN1Tomoko Lee, Yasuhiro Takeshima, Yo Okizuka, et al.
Molecular Vision|December 15, 2010
Molecular characterization of the 5'-UTR of retinal dystrophin reveals a cryptic intron that regulates translational activityIkuko Kubokawa, Yasuhiro Takeshima, Mitsunori Ota, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 23, 2013
A prostaglandin D2 metabolite is elevated in the urine of Duchenne muscular dystrophy patients and increases further from 8 years oldTaku Nakagawa, Atsuko Takeuchi, Ryohei Kakiuchi, et al.
JMIR Research Protocols|June 29, 2019
Preliminary Effectiveness and Safety of High Frequency Oscillation in Addition to Mechanical Insufflation and Exsufflation for Intratracheal Mucus Removal in Patients With Neuromuscular Disease: Protocol for a Prospective StudyHiroyuki Awano, Masashi Nagai, Ryosuke Bo, et al.
Journal of Human Genetics|April 3, 2015
Tissue- and case-specific retention of intron 40 in mature dystrophin mRNAAtsushi Nishida, Maki Minegishi, Atsuko Takeuchi, et al.
Scientific Reports|January 13, 2025
Titin fragment is a sensitive biomarker in Duchenne muscular dystrophy model mice carrying full-length human dystrophin gene on human artificial chromosomeYosuke Hiramuki, Miwa Hosokawa, Kayo Osawa, et al.
BMC Genetics|April 3, 2012
Categorization of 77 dystrophin exons into 5 groups by a decision tree using indexes of splicing regulatory factors as decision markersRusdy Ghazali Malueka, Yutaka Takaoka, Mariko Yagi, et al.
Genes|April 23, 2022
High Concentration or Combined Treatment of Antisense Oligonucleotides for Spinal Muscular Atrophy Perturbed <i>SMN2</i> Splicing in Patient FibroblastsYogik Onky Silvana Wijaya, Emma Tabe Eko Niba, Hisahide Nishio, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|November 15, 2024
Spin injection from a magnetically near-compensated state in GdFeCo and inverse spin Hall effect in electron-hole compensated metal YH<sub>2</sub>Ikuo Yamazaki, Yukihiro Koinuma, Tatsuro Hanajiri, et al.
Orphanet Journal of Rare Diseases|February 28, 2025
Analysis of SMN protein in umbilical cord blood and postnatal peripheral blood of neonates with SMA: a rationale for prompt treatment initiation to prevent SMA developmentNoriko Otsuki, Tamaki Kato, Mamoru Yokomura, et al.
Pageof 16

Showing results (81-90 of 152) with videos related to

Sort By:
Pageof 16
Gene|November 6, 2012
A Japanese child with geleophysic dysplasia caused by a novel mutation of FBN1Tomoko Lee, Yasuhiro Takeshima, Yo Okizuka, et al.
Molecular Vision|December 15, 2010
Molecular characterization of the 5'-UTR of retinal dystrophin reveals a cryptic intron that regulates translational activityIkuko Kubokawa, Yasuhiro Takeshima, Mitsunori Ota, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 23, 2013
A prostaglandin D2 metabolite is elevated in the urine of Duchenne muscular dystrophy patients and increases further from 8 years oldTaku Nakagawa, Atsuko Takeuchi, Ryohei Kakiuchi, et al.
JMIR Research Protocols|June 29, 2019
Preliminary Effectiveness and Safety of High Frequency Oscillation in Addition to Mechanical Insufflation and Exsufflation for Intratracheal Mucus Removal in Patients With Neuromuscular Disease: Protocol for a Prospective StudyHiroyuki Awano, Masashi Nagai, Ryosuke Bo, et al.
Journal of Human Genetics|April 3, 2015
Tissue- and case-specific retention of intron 40 in mature dystrophin mRNAAtsushi Nishida, Maki Minegishi, Atsuko Takeuchi, et al.
Scientific Reports|January 13, 2025
Titin fragment is a sensitive biomarker in Duchenne muscular dystrophy model mice carrying full-length human dystrophin gene on human artificial chromosomeYosuke Hiramuki, Miwa Hosokawa, Kayo Osawa, et al.
BMC Genetics|April 3, 2012
Categorization of 77 dystrophin exons into 5 groups by a decision tree using indexes of splicing regulatory factors as decision markersRusdy Ghazali Malueka, Yutaka Takaoka, Mariko Yagi, et al.
Genes|April 23, 2022
High Concentration or Combined Treatment of Antisense Oligonucleotides for Spinal Muscular Atrophy Perturbed <i>SMN2</i> Splicing in Patient FibroblastsYogik Onky Silvana Wijaya, Emma Tabe Eko Niba, Hisahide Nishio, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal|November 15, 2024
Spin injection from a magnetically near-compensated state in GdFeCo and inverse spin Hall effect in electron-hole compensated metal YH<sub>2</sub>Ikuo Yamazaki, Yukihiro Koinuma, Tatsuro Hanajiri, et al.
Orphanet Journal of Rare Diseases|February 28, 2025
Analysis of SMN protein in umbilical cord blood and postnatal peripheral blood of neonates with SMA: a rationale for prompt treatment initiation to prevent SMA developmentNoriko Otsuki, Tamaki Kato, Mamoru Yokomura, et al.
Pageof 16